Acadia Healthcare Company Overview
Latest ROE for Acadia Healthcare Company: -56.91% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-56.91%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Acadia Healthcare Company (ACHC) currently reports a ROE of -56.91%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore Acadia Healthcare Company's ROE history and peer comparisons.
Acadia Healthcare Company's ROE of -56.91% is lower than the Healthcare sector average of 29.33%. That is roughly 294.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Acadia Healthcare Company's current -56.91% should be judged against Healthcare norms (sector average: 29.33%) and against ACHC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -56.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Acadia Healthcare Company, and consider following ACHC for alerts when major investors trade the stock.
Acadia Healthcare Company is classified in the Healthcare sector. On ROE, it currently shows -56.91% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACHC with unrelated industries.
